𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Induction of apoptosis in head-and-neck squamous carcinoma cells by γ-irradiation and bleomycin is p53-independent

✍ Scribed by Vyomesh Patel; John F. Ensley; J. Silvio Gutkind; W. Andrew Yeudall


Publisher
John Wiley and Sons
Year
2000
Tongue
French
Weight
201 KB
Volume
88
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


We have examined the ability of gamma-irradiation and bleomycin to induce apoptosis in a model system consisting of cell lines derived from naturally occurring human head-and-neck squamous-cell carcinomas with contrasting p53 status and expression levels of pro- and anti-apoptotic molecules. Following exposure to gamma-irradiation (20 Gy) or bleomycin (3.5 microM) for 0 to 96 hr, cells expressing either transcriptionally inactive mutant p53 (HN6) or a truncated p53 molecule (HN19) underwent apoptosis, as assessed by fluorescence-activated cell sorting and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling, in contrast to cells that express wild-type p53 (HN30), suggesting that apoptosis induced by these agents occurs by p53-independent mechanisms. Apoptosis in HN6 and HN19 cells was preceded by a G(2)/M cell-cycle block, as analyzed by DNA content and BrdU staining. In contrast, HN30 cells remained blocked in both G(1) and G(2)/M and failed to re-enter the cell cycle. Levels of Bcl-2 were elevated in 3 of 10 cell lines, and only marginal differences were observed for Bcl-x(L). Pro-apoptotic proteins bax and Bcl-x(S) were detectable in normal keratinocytes and 4 tumor cell lines. Bax-delta (16 kDa) was highly represented in normal keratinocytes, and levels of bak were variable between cell lines. Elevated expression of Bcl-2 failed to protect HN19 cells from either gamma-irradiation or bleomycin-induced apoptosis. Our data support the existence of p53- and Bcl-2-independent pathways regulating apoptosis in keratinocytes and suggest that efficacy of either radiotherapy or bleomycin treatment for oral squamous-cell neoplasms may not, therefore, be influenced solely by endogenous p53 status.


📜 SIMILAR VOLUMES


Functional characterization of p53 molec
✍ W. Andrew Yeudall; Judit Jakus; John F. Ensley; Keith C. Robbins 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

Mutation of the p53 tumor suppressor gene has been demonstrated in a large proportion of human head and neck squamous cell carcinomas (HNSCCs) and has been assumed to play a role in the pathogenesis of these tumors, although no formal evidence of functional aberration has been demonstrated. In this

Functional characterization in vivo of m
✍ Massimo Cardinali; F. James Kratochvil; John F. Ensley; Keith C. Robbins; W. And 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB 👁 1 views

Loss of wild-type p53, either through deletion or mutation, has been demonstrated in most squamous cell carcinomas of the head and neck (HNSCC). Whether these mutant molecules contribute to tumor progression purely through loss of wild-type functions or by growth-promoting mechanisms, however, remai

Modulation of galectin-1 content in huma
✍ Ann Gillenwater; Xiao-Chun Xu; Yuval Estrov; Peter G. Sacks; Dafna Lotan; Reuben 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 397 KB 👁 1 views

Galectin-1 and galectin-3 are ␤-galactoside-binding proteins thought to be important for cellular interactions, growth regulation and differentiation. Alterations in cellular content of galectins have been associated with differentiation, transformation and malignant progression. We examined the mod